Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma-Reference-Cited by-同舟云学术

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

Published:2018-05-31 Issue:22 Volume:131 Page:2413-2425
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Spina Valeria¹,Bruscaggin Alessio¹,Cuccaro Annarosa²,Martini Maurizio³,Di Trani Martina⁴,Forestieri Gabriela¹,Manzoni Martina⁵,Condoluci Adalgisa¹⁶,Arribas Alberto¹,Terzi-Di-Bergamo Lodovico¹,Locatelli Silvia Laura⁴,Cupelli Elisa²,Ceriani Luca⁶,Moccia Alden A.⁶,Stathis Anastasios⁶,Nassi Luca⁷,Deambrogi Clara⁷,Diop Fary⁷,Guidetti Francesca¹,Cocomazzi Alessandra³,Annunziata Salvatore⁸,Rufini Vittoria⁸,Giordano Alessandro⁸,Neri Antonino⁵⁹,Boldorini Renzo¹⁰,Gerber Bernhard⁶,Bertoni Francesco¹⁶,Ghielmini Michele⁶,Stüssi Georg⁶,Santoro Armando⁴¹¹,Cavalli Franco¹⁶,Zucca Emanuele⁶,Larocca Luigi Maria³,Gaidano Gianluca⁷,Hohaus Stefan²,Carlo-Stella Carmelo⁴¹¹,Rossi Davide¹⁶

Affiliation:

1. Institute of Oncology Research, Bellinzona, Switzerland;

2. Institute of Hematology and

3. Division of Pathology, Policlinico Gemelli Foundation, Catholic University of the Sacred Heart, Rome, Italy;

4. Humanitas Cancer Center, Humanitas Clinical and Research Center, Milan, Italy;

5. Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy;

6. Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;

7. Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy;

8. Institute of Nuclear Medicine, Policlinico Gemelli Foundation, Catholic University of the Sacred Heart, Rome, Italy;

9. Hematology Unit, Foundation Ca’ Granda IRCCS, Ospedale Maggiore Policlinico, Milan, Italy;

10. Division of Pathology, Department of Health Science, University of Eastern Piedmont, Novara, Italy; and

11. Department of Biomedical Sciences, Humanitas University, Milan, Italy

Abstract

Key Points ctDNA is as an easily accessible source of tumor DNA for cHL genotyping. ctDNA is a radiation-free tool to track residual disease in cHL.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/131/22/2413/1468652/blood812073.pdf

Reference45 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

2. Hodgkin lymphoma: pathology and biology;Mathas;Semin Hematol,2016

3. Early-stage Hodgkin’s lymphoma;Armitage;N Engl J Med,2010

4. Response assessment criteria and their applications in lymphoma: part 2;Moghbel;J Nucl Med,2017

5. Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi;Luminari;Haematologica,2016

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes;Journal of Clinical Oncology;2024-02-01

2. Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy;Frontiers in Oncology;2024-01-25

3. Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers;Frontiers in Oncology;2024-01-19

4. Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas;Cancers;2024-01-11

5. Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients;Cancers;2024-01-05